MARÍA MAGDALENA
SALCEDO PLAZA
Profesora asociada de Ciencias de la Salud
Hospital Universitario Central de Asturias
Oviedo, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (23)
2024
-
The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis
Liver International, Vol. 44, Núm. 2, pp. 279-285
2023
-
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration
Hepatology, Vol. 77, Núm. 4, pp. 1095-1105
2022
-
Decreased Long-Term Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019
Liver Transplantation, Vol. 28, Núm. 6, pp. 1039-1050
-
Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study
Alimentary Pharmacology and Therapeutics, Vol. 56, Núm. 1, pp. 131-143
-
Effects of everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 6, pp. 335-342
-
Noninvasive Prediction of Outcomes in Autoimmune Hepatitis–Related Cirrhosis
Hepatology Communications, Vol. 6, Núm. 6, pp. 1392-1402
-
Sinusoidal obstruction syndrome after liver transplantation: A multicenter observational study
Liver Transplantation, Vol. 28, Núm. 7, pp. 1257-1261
2021
-
COVID-19 in Solid Organ Transplant Recipients in Spain Throughout 2020: Catching the Wave?
Transplantation, Vol. 105, Núm. 10, pp. 2146-2155
-
Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients
American Journal of Transplantation, Vol. 21, Núm. 8, pp. 2876-2884
-
Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients
Journal of Hepatology, Vol. 74, Núm. 1, pp. 148-155
2018
-
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study
American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522
2017
-
Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation
Journal of Hepatology, Vol. 67, Núm. 6, pp. 1168-1176
-
Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study
Transplant International, Vol. 30, Núm. 10, pp. 1041-1050
-
Human immunodeficiency virus–infected liver transplant recipients with incidental hepatocellular carcinoma: A prospective multicenter nationwide cohort study
Liver Transplantation, Vol. 23, Núm. 5, pp. 645-651
2016
-
Erratum: Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study (Journal of Hepatology (2015) 62 (92-100))
Journal of Hepatology
-
Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma
Hepatology, Vol. 63, Núm. 2, pp. 488-498
-
Impact of cytomegalovirus infection on severe hepatitis c recurrence in patients undergoing liver transplantation
Transplantation, Vol. 100, Núm. 3, pp. 593-599
-
Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study
American Journal of Transplantation, Vol. 16, Núm. 2, pp. 679-687
2015
-
Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study
Journal of Hepatology, Vol. 62, Núm. 1, pp. 92-100
-
Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain
Liver Transplantation, Vol. 21, Núm. 8, pp. 1056-1065